Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Overweight or Obese, Type 2 Diabetes”

212 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 212 results

Early research (Phase 1)Looking for participantsNCT07399678
What this trial is testing

Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D

Who this might be right for
Overweight or Obese AdultsOverweight or Obese, Type 2 Diabetes
Alveus Therapeutics, Inc. 180
Not applicableActive Not RecruitingNCT05874726
What this trial is testing

Biological Sample Repository for Gastrointestinal Disorders

Who this might be right for
ObesityObesity, MorbidObesity, Primary+14 more
Pichamol Jirapinyo, MD, MPH 500
Not applicableStudy completedNCT03398590
What this trial is testing

MHealth Intervention for Older Adults

Who this might be right for
Type2 DiabetesObesity
Boston College 9
Testing effectiveness (Phase 2)Looking for participantsNCT06897475
What this trial is testing

LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Who this might be right for
Type 2 Diabetes
Eli Lilly and Company 200
Not applicableStudy completedNCT04894344
What this trial is testing

Education to Decrease in Sodium Intake Evaluated With 24 Hour Urinary Sodium Excretion (RCT)

Who this might be right for
HypertensionOverweight or ObesityDiabetes Mellitus, Type 2
Universidad Autonoma de Baja California 196
Not applicableUnknownNCT03774095
What this trial is testing

Effect of Dietary Oils as G-protein-coupled Receptor Agonists on Glucose Tolerance

Who this might be right for
Type 2 Diabetes MellitusObesity
Karina Vejrum Sørensen 10
Early research (Phase 1)Study completedNCT00606112
What this trial is testing

A Single Dose, Tolerance and Pharmacokinetic Study in Obese or Overweight Type 2 Diabetic Volunteers

Who this might be right for
Diabetes MellitusObesity
Genaera Corporation 28
Not applicableStudy completedNCT05034380
What this trial is testing

Epigenetic Effects of a Single Bout of Exercise on Cardiovascular Risk Factors and the Metabolome

Who this might be right for
ObesityType 2 DiabetesCardiovascular Diseases+1 more
East Carolina University 30
Not applicableStudy completedNCT04887077
What this trial is testing

Digital Intervention Promoting Physical Activity Among Obese People (DIPPAO)

Who this might be right for
ObesityDiabete Type 2
University Hospital, Clermont-Ferrand 56
Testing effectiveness (Phase 2)UnknownNCT02069197
What this trial is testing

Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea

Who this might be right for
ObesityDiabetesObstructive Sleep Apnea
Mid-Atlantic Epilepsy and Sleep Center, LLC 150
Not applicableStudy completedNCT06912555
What this trial is testing

Effect of Low-calorie Diets With Different Macronutrient Composition and Macronutrient Distribution in Shift Workers With Prediabetes or Type 2 Diabetes and Overweight or Obesity.

Who this might be right for
Type 2 DiabetesOverweight or ObesityPreDiabetes
Universidad de Zaragoza 120
Testing effectiveness (Phase 2)Study completedNCT00231647
What this trial is testing

A Study on Efficacy and Safety of Topiramate OROS Controlled-Release in Obese, Type 2 Diabetic Subjects Managed With Diet or Metformin

Who this might be right for
ObesityDiabetes Mellitus, Type 2Diabetes Mellitus, Adult-Onset
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 113
Not applicableEnded earlyNCT02443753
What this trial is testing

EndoBarrier® SANS™ in Over-weight or Obese Type 2 Diabetic Subjects

Who this might be right for
ObesityType 2 Diabetes
Morphic Medical Inc. 7
Testing effectiveness (Phase 2)UnknownNCT05844644
What this trial is testing

The Effects of the GOLO for Life® Plan With Release Supplement on Glycemic Control and Weight in Overweight and Obese Adults With Prediabetes or Type 2 Diabetes

Who this might be right for
Type 2 DiabetesObeseOverweight+1 more
Golo 100
Testing effectiveness (Phase 2)Study completedNCT05762471
What this trial is testing

Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType2 Diabetes Mellitus
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 142
Not applicableStudy completedNCT04019431
What this trial is testing

Effect of a Very Low-Calorie Ketogenic Diet on Gut Microbiota and Fat Distribution

Who this might be right for
Obesity
University of Roma La Sapienza 50
Testing effectiveness (Phase 2)Study completedNCT01215903
What this trial is testing

Fish Gelatin Supplement and Omega-3 Supplement in Obese or Overweight Subjects With Insulin Resistance

Who this might be right for
Insulin ResistanceType 2 Diabetes
Laval University 21
Testing effectiveness (Phase 2)Study completedNCT01918865
What this trial is testing

Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObese
Ionis Pharmaceuticals, Inc. 92
Post-approval studies (Phase 4)UnknownNCT03018665
What this trial is testing

The Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese

Who this might be right for
Diabetes Mellitus, Type 2
The First Hospital of Jilin University 200
Large-scale testing (Phase 3)Active Not RecruitingNCT07104383
What this trial is testing

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

Who this might be right for
Weight Loss
Viking Therapeutics, Inc. 1,100
Next Page